Market News

US News

20 stories
globenewswire

Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026

REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. NASDAQ:RVMD, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 clinical trials evaluating zoldonrasib, its oral RA…

GlobeNewswire en
StocksUS
globenewswire

Swarmer, Tekmara and Florida International University Explore Autonomous Drone Swarms for Coastal Restoration and Environmental Monitoring

Partnership employs commercial use of drone autonomy software for large-scale ecosystem monitoring in endangered marine environmentsAUSTIN, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Swarmer, Inc. (“Swarmer” or the “Company”) NASDAQ:SWMR, a drone autonomy software company whose technology has support…

GlobeNewswire en
StocksUS
globenewswire

VisionWave Appoints Former UK Member of Parliament Ben Everitt’s Stratonex Defence Technologies as Strategic UK and European Commercialization Partner

WEST HOLLYWOOD, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. NASDAQ:VWAV (“VisionWave” or the “Company”), a defense technology company developing advanced AI-powered defense, security and autonomous systems, today announced that it has entered into a strategic Distributor Agr…

GlobeNewswire en
StocksGBUS
globenewswire

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. NASDAQ:CLRO, and change the listed company’s name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent) and “CRGT”Cortigent is a leading developer of brain computer interface (“BCI”) devices based on precis…

GlobeNewswire en
StocksUS
globenewswire

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations

Taipei, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) NASDAQ:YDES, a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic innovations, today announced that its affiliate, EG BioMed US Inc., a Delaware corporation…

GlobeNewswire en
ETFsStocksUS
globenewswire

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

Company to engage institutional investors, family offices, and military and public safety decision-makers across six events over the next three monthsVANCOUVER, British Columbia, July 02, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. NASDAQ:ZENA FSE:49Q BMV:ZENA (“ZenaTech”), a technology solution provid…

GlobeNewswire en
StocksPLUS
dow-jones

Rentokil Is Catching Up with Rollins — Market Talk

Rentokil is catching up operationally with its U.S. pest control peer Rollins, Bernstein analysts write. The London-listed group's growth-focused model emphasizes local marketing and expanding customer reach through small, satellite branches, the analysts say. As a result, the company can return to…

Dow Jones Newswires en
StocksGBUS